Skip to main navigation Skip to search Skip to main content

Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial

A. Michael Lincoff, Neal S. Kleiman, Dean J. Kereiakes, Frederick Feit, John A. Bittl, J. Daniel Jackman, Ian J. Sarembock, David J. Cohen, Douglas Spriggs, Ramin Ebrahimi, Gadi Keren, Jeffrey Carr, Eric A. Cohen, Amadeo Betriu, Walter Desmet, Wolfgang Rutsch, Robert G. Wilcox, Pim J. De Feyter, Alec Vahanian, Eric J. Topol

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science